Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

In this study, doctors are testing a new treatment for a condition called "smoldering multiple myeloma" (SMM). SMM is a type of blood cancer that isn't causing symptoms yet, but it could become more serious. The treatment involves a drug called iberdomide, which is an immunotherapy (it helps your immune system fight cancer), and sometimes it's used with another drug called dexamethasone (a synthetic steroid that helps with inflammation). They want to see how well these drugs work alone and together in stopping the cancer from growing.

• Participants will take iberdomide for 28-day cycles, with or without dexamethasone.
• The study includes regular follow-ups for 4 weeks after treatment, then every 6 months.
• Volunteers must meet specific health criteria and agree to use contraception during the study.

This study could help find better ways to treat SMM before it turns into a more serious condition. If you're interested in participating, make sure to talk to your doctor to see if you meet the requirements and understand the risks involved. 🧪🤝